Company profile
RougeTx
RougeTx is a biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction.
- Location
- Naarden, Noord-Holland, The Netherlands, Europe
- Website
- rougetx.com
Latest known funding
Series A round
- Capital
- $58M
- Announced
- Oct 6, 2026